ICU Medical Inc
NASDAQ:ICUI

Watchlist Manager
ICU Medical Inc Logo
ICU Medical Inc
NASDAQ:ICUI
Watchlist
Price: 124.19 USD -2.71% Market Closed
Market Cap: $3.1B

ICU Medical Inc
Stock-Based Compensation

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

ICU Medical Inc
Stock-Based Compensation Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Stock-Based Compensation CAGR 3Y CAGR 5Y CAGR 10Y
ICU Medical Inc
NASDAQ:ICUI
Stock-Based Compensation
$55.8m
CAGR 3-Years
16%
CAGR 5-Years
18%
CAGR 10-Years
16%
Figs Inc
NYSE:FIGS
Stock-Based Compensation
$26.9m
CAGR 3-Years
-10%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Haemonetics Corp
NYSE:HAE
Stock-Based Compensation
$31.6m
CAGR 3-Years
10%
CAGR 5-Years
6%
CAGR 10-Years
12%
Align Technology Inc
NASDAQ:ALGN
Stock-Based Compensation
$185.9m
CAGR 3-Years
12%
CAGR 5-Years
14%
CAGR 10-Years
13%
Lantheus Holdings Inc
NASDAQ:LNTH
Stock-Based Compensation
$85.6m
CAGR 3-Years
43%
CAGR 5-Years
43%
CAGR 10-Years
46%
Merit Medical Systems Inc
NASDAQ:MMSI
Stock-Based Compensation
$43.5m
CAGR 3-Years
34%
CAGR 5-Years
25%
CAGR 10-Years
35%
No Stocks Found

ICU Medical Inc
Glance View

ICU Medical Inc. emerged as an intriguing player in the healthcare sector, focusing on a mission-critical niche within the industry—safety and efficiency in medical devices for infusion therapy, oncology, and critical care applications. Founded with an innovative spirit, the company carved out a reputation by addressing a key challenge in the medical field: preventing bloodstream infections and the exposure of healthcare professionals to hazardous substances. This focus led to the development of specialized devices such as needle-free connectors and closed system transfer devices, which are integral to minimizing contamination risks. These innovations not only improved patient outcomes but also enhanced the working conditions of medical professionals, underpinning ICU Medical’s growth trajectory. ICU Medical generates revenue by designing and manufacturing these life-saving devices, which are distributed across hospitals and healthcare facilities worldwide. The company's business model revolves around creating products that align with strict regulatory standards, ensuring both safety and superiority in healthcare settings. As they ventured into diverse product lines, such as infusion pumps and systems, the firm leveraged strategic acquisitions to expand market reach and technological capabilities. These initiatives underscored ICU Medical's commitment to operational synergy and product innovation, enabling the company to remain competitive and continue scaling its operations in a constantly evolving healthcare landscape. With a steady focus on both organic growth and strategic partnerships, ICU Medical remains a crucial player in the global health economy, dedicated to advancing patient care and the efficiency of healthcare delivery systems.

ICUI Intrinsic Value
175.1 USD
Undervaluation 29%
Intrinsic Value
Price

See Also

What is ICU Medical Inc's Stock-Based Compensation?
Stock-Based Compensation
55.8m USD

Based on the financial report for Dec 31, 2025, ICU Medical Inc's Stock-Based Compensation amounts to 55.8m USD.

What is ICU Medical Inc's Stock-Based Compensation growth rate?
Stock-Based Compensation CAGR 10Y
16%

Over the last year, the Stock-Based Compensation growth was 19%. The average annual Stock-Based Compensation growth rates for ICU Medical Inc have been 16% over the past three years , 18% over the past five years , and 16% over the past ten years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett